Panion & Bf Biotech Inc. (1760.TW)
TWD 68.7
(-2.41%)
TWD 68.7
(-2.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 912.56 Million TWD | -30.79% |
| 2022 | 1.31 Billion TWD | 44.56% |
| 2021 | 912.13 Million TWD | 12.05% |
| 2020 | 814.03 Million TWD | -5.82% |
| 2019 | 864.3 Million TWD | 7.58% |
| 2018 | 803.38 Million TWD | 15.7% |
| 2017 | 694.37 Million TWD | 18.0% |
| 2016 | 588.48 Million TWD | -20.03% |
| 2015 | 735.89 Million TWD | 20.82% |
| 2014 | 609.07 Million TWD | 31.04% |
| 2013 | 464.8 Million TWD | 33.59% |
| 2012 | 347.93 Million TWD | 15.32% |
| 2011 | 301.72 Million TWD | 2.68% |
| 2010 | 293.86 Million TWD | -1.13% |
| 2009 | 297.21 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 241.98 Million TWD | -13.62% |
| 2024 Q1 | 280.13 Million TWD | 13.45% |
| 2023 Q4 | 246.92 Million TWD | -1.08% |
| 2023 FY | 912.56 Million TWD | -30.79% |
| 2023 Q1 | 217.98 Million TWD | -17.02% |
| 2023 Q2 | 244.42 Million TWD | 12.13% |
| 2023 Q3 | 249.62 Million TWD | 2.13% |
| 2022 Q1 | 235.09 Million TWD | 19.34% |
| 2022 Q3 | 345.44 Million TWD | -27.33% |
| 2022 Q4 | 262.69 Million TWD | -23.96% |
| 2022 FY | 1.31 Billion TWD | 44.56% |
| 2022 Q2 | 475.37 Million TWD | 102.21% |
| 2021 Q3 | 265.89 Million TWD | -4.64% |
| 2021 Q4 | 196.99 Million TWD | -25.91% |
| 2021 FY | 912.13 Million TWD | 12.05% |
| 2021 Q1 | 170.39 Million TWD | -38.26% |
| 2021 Q2 | 278.85 Million TWD | 63.65% |
| 2020 Q4 | 275.99 Million TWD | 39.75% |
| 2020 Q1 | 171.13 Million TWD | -32.22% |
| 2020 Q3 | 197.49 Million TWD | 16.58% |
| 2020 FY | 814.03 Million TWD | -5.82% |
| 2020 Q2 | 169.41 Million TWD | -1.01% |
| 2019 FY | 864.3 Million TWD | 7.58% |
| 2019 Q4 | 252.5 Million TWD | 36.06% |
| 2019 Q1 | 197.38 Million TWD | -26.8% |
| 2019 Q3 | 185.58 Million TWD | -18.9% |
| 2019 Q2 | 228.83 Million TWD | 15.93% |
| 2018 Q1 | 138.99 Million TWD | -24.68% |
| 2018 FY | 803.38 Million TWD | 15.7% |
| 2018 Q4 | 269.65 Million TWD | 43.45% |
| 2018 Q3 | 187.97 Million TWD | -9.08% |
| 2018 Q2 | 206.75 Million TWD | 48.75% |
| 2017 Q1 | 177.51 Million TWD | -13.79% |
| 2017 Q2 | 150.12 Million TWD | -15.43% |
| 2017 Q3 | 182.2 Million TWD | 21.36% |
| 2017 FY | 694.37 Million TWD | 18.0% |
| 2017 Q4 | 184.52 Million TWD | 1.28% |
| 2016 Q2 | 122.49 Million TWD | 0.0% |
| 2016 Q4 | 205.91 Million TWD | 49.67% |
| 2016 Q3 | 137.57 Million TWD | 12.31% |
| 2016 FY | 588.48 Million TWD | -20.03% |
| 2016 Q1 | 122.49 Million TWD | -39.32% |
| 2015 FY | 735.89 Million TWD | 20.82% |
| 2015 Q4 | 201.87 Million TWD | 0.0% |
| 2015 Q3 | 201.87 Million TWD | 21.56% |
| 2015 Q2 | 166.06 Million TWD | 0.0% |
| 2015 Q1 | 166.06 Million TWD | -3.22% |
| 2014 Q2 | 132.93 Million TWD | 0.0% |
| 2014 FY | 609.07 Million TWD | 31.04% |
| 2014 Q1 | 132.93 Million TWD | 5.41% |
| 2014 Q4 | 171.59 Million TWD | 0.0% |
| 2014 Q3 | 171.59 Million TWD | 29.08% |
| 2013 Q3 | 126.11 Million TWD | 18.66% |
| 2013 Q4 | 126.11 Million TWD | 0.0% |
| 2013 FY | 464.8 Million TWD | 33.59% |
| 2013 Q1 | 106.28 Million TWD | 9.56% |
| 2013 Q2 | 106.28 Million TWD | 0.0% |
| 2012 FY | 347.93 Million TWD | 15.32% |
| 2012 Q3 | 97.01 Million TWD | 0.0% |
| 2012 Q4 | 97.01 Million TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | 301.72 Million TWD | 2.68% |
| 2011 Q2 | - TWD | 0.0% |
| 2010 FY | 293.86 Million TWD | -1.13% |
| 2010 Q4 | - TWD | 0.0% |
| 2009 FY | 297.21 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Apex Biotechnology Corp. | 531.11 Million TWD | -71.82% |
| Sinphar Pharmaceutical Co.,Ltd. | 1.09 Billion TWD | 16.374% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 757.3 Million TWD | -20.501% |
| GenMont Biotech Incorporation | 177.33 Million TWD | -414.596% |
| Abnova (Taiwan) Corporation | 173.91 Million TWD | -424.718% |
| Adimmune Corporation | 410.93 Million TWD | -122.07% |
| Tanvex BioPharma, Inc. | 59.7 Million TWD | -1428.557% |
| Polaris Group | -137.9 Million TWD | 761.753% |
| Energenesis Biomedical CO.,LTD. | 5.22 Million TWD | -17358.657% |
| UnicoCell Biomed Co., Ltd. | 17.89 Million TWD | -4998.977% |
| PELL Bio-Med Technology Co. Ltd. | -26.14 Million TWD | 3591.064% |